A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography?

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2007-04-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMCL.2007.01.067PMID 17303417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular labeling with Gd(III) chelates: only high thermodynamic stabilities prevent the cells acting as 'sponges' of Gd3+ ions.

  2006cited by this paper
• How to determine free Gd and free ligand in solution of Gd chelates. A technical note.

  2006cited by this paper
• Targeting of lanthanide(III) chelates of DOTA-type glycoconjugates to the hepatic asyaloglycoprotein receptor: cell internalization and animal imaging studies.

  2006cited by this paper
• Can the theoretical fitting of the proton-nuclear-magnetic-relaxation-dispersion (proton NMRD) curves of paramagnetic complexes be improved by independent measurement of their self-diffusion coefficients?

  2005cited by this paper
• Development of New Glucosylated Derivatives of Gadolinium Diethylenetriaminepentaacetic for Magnetic Resonance Angiography

  2003cited by this paper
• Characteristics of a New MRI Contrast Agent Prepared From Polypropyleneimine Dendrimers, Generation 2

  2003cited by this paper
• The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.

  2002cited by this paper
• Synthesis, variable temperature and pressure 17O NMR study of bis(alkylamide) derivatives of [(Gd-DTPA)(H2O)]2- - An assessment of the substitution effect on water exchange kinetics

  2002cited by this paper
• Stability of MRI Paramagnetic Contrast Media: A Proton Relaxometric Protocol for Transmetallation Assessment

  2001cited by this paper
• Utilization of dendritic framework as a multivalent ligand: a functionalized gadolinium(III) carrier with glycoside cluster periphery

  2000cited by this paper
• Delivery of diagnostic agents for magnetic resonance imaging.

  1999cited by this paper
• A multinuclear MR study of Gd‐EOB‐DTPA: Comprehensive preclinical characterization of an organ specific MRI contrast agent

  1997cited by this paper
• Structural and Dynamic Parameters Obtained from 17O NMR, EPR, and NMRD Studies of Monomeric and Dimeric Gd3+ Complexes of Interest in Magnetic Resonance Imaging: An Integrated and Theoretically Self-Consistent Approach1

  1996cited by this paper
• Dynamic effects of pair correlation functions on spin relaxation by translational diffusion in liquids. II. Finite jumps and independent T1 processes

  1978cited by this paper
• Relaxation Processes in a System of Two Spins

  1955cited by this paper

• Gustatory Dysfunction: A Highly Specific and Smell-Independent Symptom of COVID-19

  2020cites this paper
• In Reference to Anosmia and Ageusia: Common Findings in COVID‐19 Patients

  2020cites this paper
• Polyhydroxylated GdDTPA-derivatives as high relaxivity magnetic resonance imaging contrast agents

  2015cites this paper
• Synthesis and Characterization of Ligands and their Gadolinium(III) Complexes

  2013cites this paper
• In vivo biodistribution of carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles in rats

  2011cites this paper
• Glycans in magnetic resonance imaging: determinants of relaxivity to smart agents, and potential applications in biomedicine.

  2011cites this paper
• Synthesis and characterization of multifunctional hyperbranched polyesters as prospective contrast agents for targeted MRI.

  2010cites this paper
• Tyrosine polyethylene glycol (PEG)‐micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque

  2009cites this paper
• Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent

  2009cites this paper
• Synthesis of original capping calixarenes with DTPA fragment

  2008cites this paper